Coya Therapeutics (COYA) Enterprise Value (2021 - 2026)
Coya Therapeutics (COYA) reported Enterprise Value of -$50.7 million for Q1 2026, down 42.76% on a YoY basis from -$88.6 million in Q1 2025, and down 8.33% sequentially from -$46.8 million in Q4 2025.
Coya Therapeutics (COYA) Enterprise Value (2021 - 2026) Analysis & Trends
Coya Therapeutics (COYA) has 6 years of Enterprise Value data on file, last reported at -$50.7 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 42.76% year-over-year to -$50.7 million; the trailing twelve-month figure through Mar 2026 stood at -$50.7 million (down 42.76% YoY), and the FY2025 full-year result was -$46.8 million, down 22.13% from the prior year.
- Enterprise Value slipped to -$50.7 million in Q1 2026, from -$46.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$5.9 million in Q4 2022 to a low of -$50.7 million in Q1 2026.
- A 5-year average of -$29.4 million and a median of -$31.8 million in 2023 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value sank 449.86% in 2023 and gained 18.7% in 2025, its largest moves.
- Tracing COYA's Enterprise Value over 5 years: stood at -$5.9 million in 2022, then slumped by 449.86% to -$32.6 million in 2023, then fell by 17.51% to -$38.3 million in 2024, then retreated by 22.13% to -$46.8 million in 2025, then retreated by 8.33% to -$50.7 million in 2026.
- Business Quant data shows COYA's Enterprise Value at -$50.7 million in Q1 2026, -$46.8 million in Q4 2025, and -$28.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -1.91 Bn |
| 10 | Coya Therapeutics | 97.14 Mn | 46.42 Mn | - | -50.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.72 Mn |
| Dec 31, 2025 | -46.82 Mn |
| Sep 30, 2025 | -28.13 Mn |
| Jun 30, 2025 | -29.76 Mn |
| Mar 31, 2025 | -35.53 Mn |
| Dec 31, 2024 | -38.34 Mn |
| Sep 30, 2024 | -31.06 Mn |
| Jun 30, 2024 | -36.60 Mn |
| Mar 31, 2024 | -35.99 Mn |
| Dec 31, 2023 | -32.63 Mn |
| Sep 30, 2023 | -10.89 Mn |
| Jun 30, 2023 | -13.10 Mn |
| Mar 31, 2023 | -16.32 Mn |
| Dec 31, 2022 | -5.93 Mn |
| Dec 31, 2021 | -4.34 Mn |